March 12, 2020
Santen Pharmaceutical and US-based Tracon Pharmaceuticals jointly said on March 10 that the companies will pull the plug on the development of their investigational compound DE-122 for the treatment of wet age-related macular degeneration (wAMD) based on the analysis of...read more